Item(by='CoolGuySteve', descendants=None, kids=[25825950], score=None, time=1611000044, title=None, item_type='comment', url=None, parent=25825417, text='That may be true but the USSR is a collapsed state, we should be comparing wealthy countries.<p>According to this the US is mostly in the high top 10 for outcomes in cancer and cardiovascular disease treatment outcomes:<p><a href="https:&#x2F;&#x2F;en.wikipedia.org&#x2F;wiki&#x2F;List_of_countries_by_quality_of_healthcare#Outcome_of_cardiovascular_disease_care" rel="nofollow">https:&#x2F;&#x2F;en.wikipedia.org&#x2F;wiki&#x2F;List_of_countries_by_quality_o...</a><p>But the US spends more than double the OECD average per capita to achieve those marginal gains:<p><a href="https:&#x2F;&#x2F;upload.wikimedia.org&#x2F;wikipedia&#x2F;commons&#x2F;thumb&#x2F;0&#x2F;0b&#x2F;OECD_health_expenditure_per_capita_by_country.svg&#x2F;1920px-OECD_health_expenditure_per_capita_by_country.svg.png" rel="nofollow">https:&#x2F;&#x2F;upload.wikimedia.org&#x2F;wikipedia&#x2F;commons&#x2F;thumb&#x2F;0&#x2F;0b&#x2F;OE...</a><p>There&#x27;s an argument to be made that the cost overruns are paying for better outcomes, or maybe the outcomes have some sample bias due to Americans being less healthy, or sicker people are seeking treatment in the US.<p>But on the other hand, the gains are so marginal that those costs might also be due to significant corruption and regulatory capture.')